Edgewise Therapeutics Shares Decline Amid Wider Q1 Loss
Idag, 15:35
Idag, 15:35
09:35 AM EDT, 05/07/2026 (MT Newswires) -- Edgewise Therapeutics (EWTX) retreated more than 1% in morning trading Thursday as the company reported a wider Q1 loss.
The company reported a Q1 net loss of $0.46 per diluted share, compared with a loss of $0.43 a year earlier.
Four analysts polled by FactSet expected a loss of $0.49.
As expected, no revenue was reported for the quarter ended March 31.
The company said it had cash, cash equivalents and marketable securities of about $499.6 million as of March 31.
Price: 36.44, Change: -0.55, Percent Change: -1.48
Idag, 15:35
09:35 AM EDT, 05/07/2026 (MT Newswires) -- Edgewise Therapeutics (EWTX) retreated more than 1% in morning trading Thursday as the company reported a wider Q1 loss.
The company reported a Q1 net loss of $0.46 per diluted share, compared with a loss of $0.43 a year earlier.
Four analysts polled by FactSet expected a loss of $0.49.
As expected, no revenue was reported for the quarter ended March 31.
The company said it had cash, cash equivalents and marketable securities of about $499.6 million as of March 31.
Price: 36.44, Change: -0.55, Percent Change: -1.48
Svensk ekonomi
Analys
Lyxsektorn
Riksdagsvalet 2026
Svensk ekonomi
Analys
Lyxsektorn
Riksdagsvalet 2026
1 DAG %
Senast
OMX Stockholm 30
−1,21%
(16:56)
OMX Stockholm 30
1 DAG %
Senast
3 121,05